Gender dysphoria and affirming care — structured clinical viva

Formulation. Adult transgender woman with likely gender dysphoria historically treated with GAHT; current major depression and high-lethality suicide attempt in the context of minority stress (workplace discrimination) and possible residual body dysphoria. Identity is not the "illness"; the crisis is a mental health emergency within a stigmatising social context.[1][7][2]

Acute priorities. Medical clearance post-overdose; full suicide risk assessment; means restriction; least restrictive safe setting; rebuild alliance using affirmed name/pronouns; do not force conversion narratives. Treat depression urgently with standard pathways (psychotherapy ± antidepressant, monitoring).[2][6]

Surgery demand. Affirm desire for congruence but do not rubber-stamp "surgery tomorrow" during acute suicidality and untreated depression. Surgical readiness includes stable decision-making capacity, realistic expectations, and multidisciplinary process — surgery is not an emergency antidepressant. Explain that many people benefit psychosocially from medical transition while long-term cohorts still show residual elevated suicide risk versus population baselines, so mental health care remains essential.[5][3][4][8]

Differential/comorbidity. MDD primary now; screen PTSD, SUD, BDD-like residual concerns, personality vulnerability; ensure hormone safety liaison with endocrine/GP (VTE risk, adherence).[1][6]

Plan. Crisis stabilisation → treat depression → workplace/advocacy supports → coordinated gender-service surgical pathway when clinically appropriate → long-term MH follow-up. Collaborative stance: "Your identity is respected; your life is the priority today; both gender care and mental health care matter."[5][6]